Rodney Lappe

Rodney Lappe

Director/Board Member chez DESIGN THERAPEUTICS, INC.

Fortune : 536 087 $ au 31/03/2024

69 ans
Health Technology
Consumer Services
Finance

Profil

Rodney W.
Lappe
is currently the Director at Nucleus Biologics LLC and an Independent Director at Design Therapeutics, Inc. He previously worked as a Director at Mirati Therapeutics, Inc. and held the position of Senior Vice President at Tavistock Life Sciences Co. He also served as the VP-Cardiovascular & Metabolic Diseases at Pharmacia Corp.
and as the Group SVP-Worldwide Research & Development at Pfizer Inc. Additionally, he was the Chief Scientific Officer & Senior Vice President at CovX Research LLC.
Dr. Lappe completed his undergraduate degree at Blackburn College and obtained his doctorate from Indiana University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/12/2023 133 024 ( 0,24% ) 536 087 $ 31/03/2024

Postes actifs de Rodney Lappe

SociétésPosteDébut
DESIGN THERAPEUTICS, INC. Director/Board Member 01/07/2019
Director/Board Member -
Tous les postes actifs de Rodney Lappe

Anciens postes connus de Rodney Lappe

SociétésPosteFin
MIRATI THERAPEUTICS Chairman 15/02/2019
Chief Tech/Sci/R&D Officer 01/12/2011
PFIZER, INC. Chief Tech/Sci/R&D Officer 01/12/2011
Corporate Officer/Principal 01/12/2003
Corporate Officer/Principal -
Voir l'expérience en détail de Rodney Lappe

Formation de Rodney Lappe

Blackburn College Undergraduate Degree
Indiana University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Rodney Lappe

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
PFIZER, INC.

Health Technology

Entreprise privées6

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Design Therapeutics, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Rodney Lappe